** Oncosil Medical OSL.AX slides as much as 28.6% to a record low of A$0.003; last down 14.3%
** Pharmaceutical co announces A$8.7 mln ($5.7 mln) capital raise at an issue price of A$0.003, a 25% discount to stock's last close
** Says proceeds will fund and accelerate the ongoing commercialization of Oncosil medical device used to treat pancreatic cancer
** Nearly 50 mln shares traded vs 30-day avg of 3 mln
** Stock falls 41.7% this year, as of last close
($1 = A$1.5335)
(Reporting by Roshan Thomas in Bengaluru)
((Roshan.Thomas@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.